Categories
Breast Cancer

Final results from PALLAS: adjuvant palbociclib in HR+/HER2- early breast cancer [Video]

Final results from PALLAS: adjuvant palbociclib in HR+/HER2- early breast cancer

Michael Gnant, MD, Medical University of Vienna, Vienna, Austria, shares the final results from the randomized, Phase III PALLAS trial (NCT02513394). PALLAS investigated whether the addition of the CDK4/6 inhibitor, palbociclib, to adjuvant endocrine therapy improves outcomes over endocrine therapy alone in patients with hormone receptor-positive, HER2-negative early breast cancer. The addition of palbociclib did not improve survival endpoints in this patient population; whether the addition of CDK4/6 inhibition to particular subgroups of patients is being investigated. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.

Watch/Read More
Categories
Breast Cancer

New breast cancer drug delivers unprecedented levels of survival, stopping tumor growth [Video]

A trial of a newly approved breast cancer drug in patients who are not typically targeted by the drug resulted in extremely encouraging results never seen before. Patients who received the drug survived longer and had lower growth in their tumours than those who received standard chemotherapy. ThePrint’s Sandhya Ramesh explains the findings.Brought to by @Kia India To know more, read: https://theprint.in/health/experimental-drug-shows-success-in-advanced-breast-cancer-patients-better-than-standard-chemo/995701/Subscribe to the Pure Science Telegram Channel https://t.me/PureScienceWithSandhyaRameshSupplementary reading: Modi, S., et al.; The New England Journal of Medicine (2022) Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer https://www.nejm.org/doi/full/10.1056/NEJMoa2203690---------------------------------------------------------------------------------------------Join our channel to get access to perks. Click 'JOIN' or follow the link below:https://www.youtube.com/channel/UCuyRsHZILrU7ZDIAbGASHdA/join---------------------------------------------------------------------------------------------Connect with ThePrint» Subscribe to ThePrint: https://theprint.in/subscribe/» Subscribe to our YouTube Channel: https://bit.ly/3nCMpht» Like us on Facebook: https://www.facebook.com/theprintindia» Tweet us on Twitter: https://twitter.com/theprintindia» Follow us on Instagram: https://www.instagram.com/theprintindia» Find us on LinkedIn : https://www.linkedin.com/company/theprint» Subscribe to ThePrint on Telegram: https://t.me/ThePrintIndia» Find us on Spotify: https://spoti.fi/2NMVlnB» Find us on Apple Podcasts: https://apple.co/3pEOta8

Categories
Breast Cancer

Oklahoma Gov. signs bill requiring insurance coverage of diagnostic mammograms [Video]

Breast cancer survivors and Oklahoma lawmakers are calling it legislation that will save lives. At-risk patients will now get financial help to catch the deadly disease early.Stay informed about Oklahoma news and weather! Follow KFOR News 4 on our website and social channels. https://kfor.com/https://www.youtube.com/c/kfor4newshttps://www.facebook.com/kfor4https://twitter.com/kforhttps://www.instagram.com/kfortv4/

Categories
Breast Cancer

Breast cancer drug Enhertu shows promise against some tumors, opening new treatment possibilities to thousands of patients [Video]

A drug targeting a protein that drives breast cancer growth has been shown to work against tumors with very low levels of the protein.